Agenda - DARWIN EU Advisory Board - 25 November 2024
Submitted by Anonymous (not verified) on 26 November 2025 - 9:19
Agenda - DARWIN EU Advisory Board - 25 November 2024
Regulatory Procedure Management in IRIS roadmap
Submitted by Anonymous (not verified) on 26 November 2025 - 9:15
Regulatory Procedure Management in IRIS roadmap
Type-IB variations: questions and answers
Submitted by Anonymous (not verified) on 26 November 2025 - 9:15
Type-IB variations: questions and answers
Type-IA variations: questions and answers
Submitted by Anonymous (not verified) on 26 November 2025 - 9:12
Type-IA variations: questions and answers
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with tracked changes
Submitted by Anonymous (not verified) on 26 November 2025 - 9:00
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with tracked changes
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
Submitted by Anonymous (not verified) on 26 November 2025 - 9:00
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
Expected publication dates of PRAC recommendations on safety signals
Submitted by Anonymous (not verified) on 26 November 2025 - 8:45
Expected publication dates of PRAC recommendations on safety signals
Human medicines European public assessment report (EPAR): Hympavzi, marstacimab, Date of authorisation: 18/11/2024, Revision: 2, Status: Authorised
Submitted by Anonymous (not verified) on 25 November 2025 - 16:50
Human medicines European public assessment report (EPAR): Hympavzi, marstacimab, Date of authorisation: 18/11/2024, Revision: 2, Status: Authorised
Withdrawn application: Vectra 3D, 27/11/2024
Submitted by Anonymous (not verified) on 25 November 2025 - 16:45
Withdrawn application: Vectra 3D, 27/11/2024
Human medicines European public assessment report (EPAR): Hydrocortisone Aguettant, Status: Application withdrawn
Submitted by Anonymous (not verified) on 25 November 2025 - 16:20
Human medicines European public assessment report (EPAR): Hydrocortisone Aguettant, Status: Application withdrawn